PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

Development and validation of a new isocratic RP-HPLC method for simultaneous determination of sodium metabisulfite and sodium benzoate in pharmaceutical formulation

Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
A simple and convenient reversed-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous separation, identification, and determination of sodium metabisulfite and sodium benzoate in pharmaceutical formulation has been developed and validated. Chromatographic separation was achieved on RP column Zorbax Extend C-18 (150 × 4.6 mm i.d., 3.5 μm particles), and mixture of 0.1% phosphoric acid and acetonitrile in the ratio 62:38 (v/v) was used as a mobile phase. The flow rate was set at 1.0 mL/min with detection wavelength of 275 nm. The method was successfully validated according to International Conference on Harmonization (ICH) guidelines acceptance criteria. The method is selective, as no interferences were observed at retention times corresponding to these analytes. Results of regression analyses (r) and statistical insignificance of calibration curve intercepts (p) proved linearity of the method in defined concentration ranges for sodium metabisulfite and sodium benzoate (0.05–0.15 mg/mL). Relative standard deviations calculated for both analytes in precision testing were below the limits defined for active pharmaceutical ingredients (analysis repeatability: <2%; intermediate precision: <3%). Recovery values were between 98.16% and 101.94%. According to results of robustness testing, chromatographic parameters are not significantly influenced by small variation of acetonitrile content in mobile phase, column temperature, and flow rate. Finally, the method was applied for quantitative determination of investigated preservatives in real sample analysis.
Rocznik
Strony
133--137
Opis fizyczny
Bibliogr. 32 poz., rys.
Twórcy
autor
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Republic of Serbia
autor
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Republic of Serbia
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Republic of Serbia
autor
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Republic of Serbia
Bibliografia
  • [1] ICH Harmonised Tripartite Guideline, Specifications Q6A: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances, 1999.
  • [2] Rowe, R. X. C.; Sheskey, P. J.; Quinn, M. E. (eds.), Handbook of Pharmaceutical Excipients, sixth ed.; Pharmaceutical Press: London, 2009.
  • [3] da Costa Machado Matos Carvalho, I. M.; Cavalcante, A. A.; Dantas, A. F.; Pereira, D. L.; Rocha, F. C.; de Oliveira, F. M.; Da Silva, J. Chemosphere 2011, 82, 1056.
  • [4] da Costa Machado Matos Carvalho, I. M.; Cavalcante, A. A.; Dantas, A. F.; Pereira, D. L.; Rocha, F. C.; Andraded, T. J.; Da Silva, J. Mutat. Res. 2011, 720, 58.
  • [5] Rencüzoğullari, E.; Basri Ila, H.; Kayraldiz, A.; Topaktaş, M. Mutat. Res.-Gen. Tox. En. 2001 490, 107.
  • [6] Til, H. P.; Feron, V. J. Food Addit. Contam. A 1992 9, 587.
  • [7] Kumar, T. N.; Rao, K. C.; Sreenivasulu, R.; Mallu, U. R. IJSID 2011, 1, 469.
  • [8] Podolska, M.; Białecka, W.; Kulik, A.; Kwiatkowska-Puchniarz, B.; Mazurek, A. Acta Pol. Pharm. 2011, 68, 637.
  • [9] Parshaa, S.; Ravindra Kumara, Y.; Ravi Chanderb, M. J. Pharm. Biol. Sci. 2014, 9, 24.
  • [10] Taylor, R. H.; Rotermund, J.; Christian, G. D.; Ruzicka, J. Talanta 1994, 41, 31.
  • [11] Quintino, M. S. M.; Araki, K.; Toma, H. E.; Angnes, L. Talanta 2006, 68, 1281.
  • [12] Geiser, L.; Varesio, E.; Veuthey, J.-L. J. Pharm. Biomed. Anal. 2003, 31, 1059.
  • [13] Nováková, M.; Křivánková, L.; Bartoš, M.; Urbanová, V.; Vytřas, K. Talanta 2007, 74, 183.
  • [14] Nair, B. Int. J. Toxicol. 2001, 20, 23.
  • [15] Gören, A.; Bilsel, G.; Şimşek, A.; Bilsel, M.; Akçadağ, F.; Topal, K.; Osgen, H. Food Chem. 2015, 175, 273.
  • [16] Mazdeh, F. Z.; Moradi, Z.; Moghaddam, G.; Moradi-Khatoonabadi, Z.; Aftabdari, F. E.; Badaei, P.; Hajimahmoodi, M. Trop. J. Pharm. Res. 2016, 15, 183.
  • [17] Grembecka, M.; Baran, P.; Błazewicz, A.; Fijałek, Z.; Szefer, P. Eur. Food Res. Technol. 2014, 238, 357.
  • [18] Mazdeh, F. Z.; Sasanfar, S.; Chalipour, A.; Pirhadi, E.; Yahyapour, G.; Mohammadi, A.; Rostami, A.; Amini, M.; Hajimahmoodi, M. Int. J. Anal. Chem. https://doi.org/10.1155/2017/3084359.
  • [19] Abdollahpoura, A.; Forouhib, M.; Shamsipurc, M.; Yaminia, Y. J. Iran. Chem. Soc. 2010, 7, 516.
  • [20] Zahálka, L.; Matysová, L.; Šklubalová, Z.; Klovrzovà, S.; Solich, P. Chromatographia 2013, 76, 1553.
  • [21] El-Gindy, A.; Attia, K.; Nassar, M.; Abu Seada, H.; Shoeib, M. J. Liq. Chromatogr. Relat. Technol. 2013, 36, 1251.
  • [22] Debbih, M.; Guermouche, M. H.; Guermouche, S. Chem. Pap. 10.1007/s11696-017-0162-3.
  • [23] Baranowska, I.; Wojciechowska, I.; Solarz, N.; Krutysza, E. J. Chromatogr. Sci. 2014, 52, 88.
  • [24] Baranowska, I.; Wojciechowska, I. Pol. J. Environ. Stud. 2013, 22, 1609.
  • [25] Mahboubifar, M.; Sobhani, Z.; Dehghanzadeh, G.; Javidnia, K. Food Anal. Methods 2011, 4, 150.
  • [26] Wang, Y.; Ni, C.; Zhao, M.; Liu, Y. J. Food Process. Pres. 10.1111/j.1745-4549.2012.00804.x.
  • [27] Zhang, H.; Qi, L.; Qiao, J.; Mao, L. Anal. Chim. Acta 2011, 691, 103.
  • [28] Rena, L.; Menga, M.; Wanga, P.; Xua, Z.; Ereminc, S. A.; Zhaod, J.; Yina, Y.; Xia, R. Talanta 2014, 121, 136.
  • [29] Sun, C.; Sun, X.; Aboul-Enein, H. Anal. Lett. 2010 43, 1989.
  • [30] International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2(R1), 2005, ICH: Geneva.
  • [31] Yang, Z.; Zhang, Y.; Zhang, Q.; Pei, T.; Meng, Z. Procedia Environ. Sci. 2013, 18, 92.
  • [32] J. Crowther in Ahuja, S.; Scypinsky, S. (eds.), Handbook of Modern Pharmaceutical Analysis; Academic Press: San Diego, 2001
Uwagi
PL
Opracowanie rekordu w ramach umowy 509/P-DUN/2018 ze środków MNiSW przeznaczonych na działalność upowszechniającą naukę (2019).
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-ce5ea6dc-ca30-4c83-ac02-85e2fa2c16c1
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.